It is a pharma public limited company based in Indore, Madhya Pradesh, India, established in 1995.
1995 | Indore, Madhya Pradesh, India | Converted to LLPCanary Pharma Limited, a converted to llp public limited company, was established on 17 January 1995 in Indore, Madhya Pradesh, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24232MP1995PLC008940. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹1.80 M and a paid-up capital of ₹1.80 M.
It upholds a compliant status. Its leadership includes Kiran Deshmukh (Director), Ankit Mehta (Director), Prateek Deshmukh (Director). Past directors included Sanjay Mirikar, Ankit Mehta, Neena Bhatjiwale. Its latest AGM occurred on 15 June 2023, with the balance sheet filed on 31 March 2023. It is based at 12, Rajgadh Kothi, Manoramaganj Behind United Tyres, Indore, Madhya Pradesh, 452001.
U24232MP1995PLC008940
008940
17 January 1995
₹1.80 M
₹1.80 M
Roc Gwalior
Unlisted
Converted to LLP
Explore comprehensive insights into Canary Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kiran Deshmukh | Director | 21 Jun 2006 | Current |
| Ankit Mehta | Director | 12 Mar 2012 | Current |
| Prateek Deshmukh | Director | 01 Mar 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 05 Mar 2019 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2012 | Past |
| Pramod Abcsdd | Director | 29 Sep 2012 | Past |
| Pramod Abcsdd | Director | 29 Sep 2012 | Past |
| Pramod Abcsdd | Director | 29 Sep 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Canary Pharma Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 234.85% decrease in profit. The company's net worth dipped by a decrease of 0.52%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Canary Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Canary Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Canary Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Canary Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Canary Pharma Limited last Annual general meeting of members was held on 15 Jun 2023 as per latest MCA records. was completed.
Progress on Canary Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Gwalior. was documented.
Prateek Deshmukh was appointed as a Director was appointed as a Director on 01 Mar 2019 & has been associated with this company since 6 years 9 months . was recorded as a recent event.
The activity Ankit Mehta was appointed as a Director was appointed as a Director on 12 Mar 2012 & has been associated with this company since 13 years 8 months . was completed.
Progress on Kiran Deshmukh was appointed as a Director was appointed as a Director on 21 Jun 2006 & has been associated with this company since 19 years 5 months . was documented.
Progress on Canary Pharma Limited was registered on 17 Jan 1995 with Roc Gwalior & aged 30 years 10 months as per MCA records. was documented.
The CIN of Canary Pharma Limited is U24232MP1995PLC008940.
Canary Pharma Limited is headquartered at 12, Rajgadh Kothi, Manoramaganj Behind United Tyres, Indore, Madhya Pradesh, 452001.
Canary Pharma Limited was incorporated on 17 January 1995.
The current directors of Canary Pharma Limited are
The primary industry of Canary Pharma Limited is Pharma.
Canary Pharma Limited is unlisted.
The authorized capital of Canary Pharma Limited is ₹1.80 M, and the paid-up capital is ₹1.80 M.
The compliance status of Canary Pharma Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX